West Pharmaceutical Services
NYSE:WST Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 17 Fair Values set on narratives written by author
WA
Consensus Narrative from 10 Analysts
Investments In Wearable Self-Injection Devices And GLP-1 Drugs Will Open Future Markets
Key Takeaways Growth in wearable self-injection devices and GLP-1 drugs presents significant revenue opportunities as demand and markets expand. Investments in capacity expansion and manufacturing efficiency are poised to enhance margins and drive future earnings.
View narrativeUS$379.85
FV
44.5% undervalued intrinsic discount6.63%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
24 days ago author updated this narrative